Amman:The specialized inspection and oversight teams of the Jordan Food and Drug Administration (JFDA) have seized quantities of an unapproved medical product known as "Fresh Dream Eye Hyaluronic Acid," which is a contact lens solution.
According to Jordan News Agency, the JFDA announced that its inspection teams have confiscated the product and initiated legal action against the violating entities. These actions are part of their efforts to ensure the protection of public health and safety, in accordance with applicable legislation.
The JFDA has urged citizens to refrain from purchasing or using this unapproved product and has stated that inspection campaigns will continue nationwide. These campaigns aim to verify compliance with established requirements and standards for the distribution of medical supplies.
This initiative is part of JFDA's regulatory role in ensuring the safety, quality, and efficacy of medical products available in the local market, thereby ensuring consumers receive safe, high-quality, and effective medical supplies.
As a precaution, the JFDA advises citizens to confirm that any medical product is approved or registered with their administration before use to safeguard their health and safety. The public is encouraged to contact the JFDA via its official complaints platform on WhatsApp at 0795632000 or through the toll-free complaints hotline at 117114 to report any concerns, inquiries, or grievances.